Pardes Biosciences Inc (PRDS) Stock
PRDS is no longer traded. Pardes Biosciences was delisted from the Nasdaq in August 2023.
Prices on this page are historical; the last trade was August 29, 2023 at $2.16.
Pardes Biosciences stock price history
PRDS final trading statistics
- Final close
- $2.16
- Final trading day
- Aug 29, 2023
- Market cap at delisting
- $133.95M
- Shares outstanding
- 62.01M
- Final 52-week range
- $0.75 – $3.67
- Avg. volume (final 3 mo.)
- 510,241
- All-time high (split-adj.)
- $17.02 · Dec 2021
- All-time low (split-adj.)
- $0.85 · Nov 2022
- Return since IPO
- -80.0%
- Beta
- 0.42
- Book value / share
- $2.57
- Price / book
- 0.84
Pardes Biosciences annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $0.00 | -$93.5M | -$1.67 |
| FY2021 | $0.00 | -$38.5M | -$0.20 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Pardes Biosciences Inc
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to treat and prevent viral diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California. As of August 31, 2023, Pardes Biosciences, Inc. operates as a subsidiary of MediPacific, Inc.
Pardes Biosciences stock FAQ
What happened to Pardes Biosciences stock?
Pardes Biosciences stock was delisted from the Nasdaq. Its final close was $2.16 on August 29, 2023.
Is PRDS stock still trading?
No. PRDS was delisted from the Nasdaq in August 2023 and no longer trades on a U.S. exchange.
What was the last price of PRDS stock?
PRDS closed at $2.16 on its final trading day, August 29, 2023, for a market value of about $133.95M.
What were Pardes Biosciences's revenue and earnings in its last full fiscal year?
Pardes Biosciences reported revenue of $0.00 and net income of -$93.5M in fiscal 2022, its last full year as a public company.
When did Pardes Biosciences go public?
Pardes Biosciences Inc stock began trading on December 27, 2021.